OcellO is a CRO offering drug testing in 3D cultured human tissues. Unique high-throughput, high-content 3D imaging platform developed at OcellO that faithfully recapitulate complex human biology is used to visualize and quantify treatment effects. We test drug candidates for oncology, immuno-oncology, inflamation and cystopathy indications helping our customers to discover the full potential of their compounds. OcellO uses a proprietary best-in-class high throughput 3D cell culture-based screening platform. This technology allows high content imaging to be applied to compound screening, lead and target validation, providing rich information about compound properties.